Literature DB >> 32195019

Experimental model for the irradiation-mediated abscopal effect and factors influencing this effect.

Kiichiro Baba1, Motoo Nomura1, Shinya Ohashi1, Takuya Hiratsuka2, Yukie Nakai1, Tomoki Saito1, Yuki Kondo1, Keita Fukuyama1, Osamu Kikuchi1, Atsushi Yamada1, Junichi Matsubara1, Kenshiro Hirohashi1, Yosuke Mitani1, Ayaka Mizumoto1, Manabu Muto1.   

Abstract

Radiotherapy (RT) is the primary treatment for cancer. Ionizing radiation from RT induces tumor damage at the irradiated site, and, although clinically infrequent, may cause regression of tumors distant from the irradiated site-a phenomenon known as the abscopal effect. Recently, the abscopal effect has been related to prolongation of overall survival time in cancer patients, though the factors that influence the abscopal effect are not well understood. The aim of this study is to clarify the factors influencing on abscopal effect. Here, we established a mouse model in which we induced the abscopal effect. We injected MC38 (mouse colon adenocarcinoma) cells subcutaneously into C57BL/6 mice at two sites. Only one tumor was irradiated and the sizes of both tumors were measured over time. The non-irradiated-site tumor showed regression, demonstrating the abscopal effect. This effect was enhanced by an increase in the irradiated-tumor volume and by administration of anti-PD1 antibody. When the abscopal effect was induced by a combination of RT and anti-PD1 antibody, it was also influenced by radiation dose and irradiated-tumor volume. These phenomena were also verified in other cell line, B16F10 cells (mouse melanoma cells). These findings provide further evidence of the mechanism for, and factors that influence, the abscopal effect in RT. AJCR
Copyright © 2020.

Entities:  

Keywords:  Abscopal effect; anti-PD1 antibody; irradiated-tumor volume; radiation dose; radiotherapy; tumor-specific CD8+ T cells

Year:  2020        PMID: 32195019      PMCID: PMC7061743     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  27 in total

1.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

Review 2.  Innovations in image-guided radiotherapy.

Authors:  Dirk Verellen; Mark De Ridder; Nadine Linthout; Koen Tournel; Guy Soete; Guy Storme
Journal:  Nat Rev Cancer       Date:  2007-12       Impact factor: 60.716

3.  PD-L1 mediated the differentiation of tumor-infiltrating CD19+ B lymphocytes and T cells in Invasive breast cancer.

Authors:  Honggeng Guan; Yang Lan; Yuqiu Wan; Qin Wang; Cheng Wang; Longjiang Xu; Yongjing Chen; Wenting Liu; Xueguang Zhang; Yecheng Li; Yongping Gu; Zemin Wang; Fang Xie
Journal:  Oncoimmunology       Date:  2015-08-12       Impact factor: 8.110

Review 4.  Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules.

Authors:  P A Henkart
Journal:  Immunity       Date:  1994-08       Impact factor: 31.745

Review 5.  Opportunities and challenges of radiotherapy for treating cancer.

Authors:  Dörthe Schaue; William H McBride
Journal:  Nat Rev Clin Oncol       Date:  2015-06-30       Impact factor: 66.675

6.  Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape.

Authors:  Janis M Taube; Robert A Anders; Geoffrey D Young; Haiying Xu; Rajni Sharma; Tracee L McMiller; Shuming Chen; Alison P Klein; Drew M Pardoll; Suzanne L Topalian; Lieping Chen
Journal:  Sci Transl Med       Date:  2012-03-28       Impact factor: 17.956

7.  Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody.

Authors:  M Zahidunnabi Dewan; Ashley E Galloway; Noriko Kawashima; J Keith Dewyngaert; James S Babb; Silvia C Formenti; Sandra Demaria
Journal:  Clin Cancer Res       Date:  2009-08-25       Impact factor: 12.531

8.  Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion.

Authors:  Haidong Dong; Scott E Strome; Diva R Salomao; Hideto Tamura; Fumiya Hirano; Dallas B Flies; Patrick C Roche; Jun Lu; Gefeng Zhu; Koji Tamada; Vanda A Lennon; Esteban Celis; Lieping Chen
Journal:  Nat Med       Date:  2002-06-24       Impact factor: 53.440

9.  Membranous and Cytoplasmic Expression of PD-L1 in Ovarian Cancer Cells.

Authors:  Qiu-Xia Qu; Fang Xie; Qin Huang; Xue-Guang Zhang
Journal:  Cell Physiol Biochem       Date:  2017-10-20

10.  Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation.

Authors:  G J Freeman; A J Long; Y Iwai; K Bourque; T Chernova; H Nishimura; L J Fitz; N Malenkovich; T Okazaki; M C Byrne; H F Horton; L Fouser; L Carter; V Ling; M R Bowman; B M Carreno; M Collins; C R Wood; T Honjo
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

View more
  7 in total

Review 1.  Synergistic effects of radiotherapy and targeted immunotherapy in improving tumor treatment efficacy: a review.

Authors:  Tahir Bashir Dar; Fleury Augustin Nsole Biteghe; Ruchi Kakar-Bhanot; Eric Chekwebe Aniogo; Zaria Malindi; Olusiji Alex Akinrinmade; Nyangone Ekome Toung Chalomie; Arnaud John Kombe Kombe; Sophie Aboughe Angone; Jean Marc Ngome Ndong; Jean Delacroix Ndong
Journal:  Clin Transl Oncol       Date:  2022-08-01       Impact factor: 3.340

Review 2.  Immunostimulatory Effects of Radiotherapy for Local and Systemic Control of Melanoma: A Review.

Authors:  Junko Takahashi; Shinsuke Nagasawa
Journal:  Int J Mol Sci       Date:  2020-12-07       Impact factor: 5.923

Review 3.  The Role of Tumor-Derived Exosomes in the Abscopal Effect and Immunotherapy.

Authors:  Zechen Shan; Hongmei Wang; Yujuan Zhang; Weiping Min
Journal:  Life (Basel)       Date:  2021-04-23

4.  Induction of Bystander and Abscopal Effects after Electroporation-Based Treatments.

Authors:  Paulius Ruzgys; Diana Navickaitė; Rūta Palepšienė; Dovilė Uždavinytė; Neringa Barauskaitė; Vitalij Novickij; Irutė Girkontaitė; Brigita Šitkauskienė; Saulius Šatkauskas
Journal:  Cancers (Basel)       Date:  2022-08-02       Impact factor: 6.575

Review 5.  Local Destruction of Tumors and Systemic Immune Effects.

Authors:  Karl-Göran Tranberg
Journal:  Front Oncol       Date:  2021-07-08       Impact factor: 6.244

6.  Abscopal Effects of Local Radiotherapy Are Dependent on Tumor Immunogenicity.

Authors:  Jin-Zhi Lai; Yan-Yang Zhu; Ying Liu; Lin-Lin Zhou; Li Hu; Ling Chen; Qiu-Yu Zhang
Journal:  Front Oncol       Date:  2021-06-24       Impact factor: 6.244

7.  Cisplatin-based chemoradiation decreases telomerase-specific CD4 TH1 response but increases immune suppressive cells in peripheral blood.

Authors:  Jihane Boustani; Elodie Lauret Marie Joseph; Etienne Martin; Salim Benhmida; Benoit Lecoester; Florent Tochet; Céline Mirjolet; Cédric Chevalier; David Thibouw; Noémie Vulquin; Stéphanie Servagi; Xushan Sun; Olivier Adotévi
Journal:  BMC Immunol       Date:  2021-06-18       Impact factor: 3.615

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.